CPR Pharma 2016

CPR has gained a solid reputation for our ability to rescue clinical trials.  Approached by sponsors facing a clinical trial failure due to an array of reasons, from failed assays, looming FDA/EMA submission deadlines or the closure of competitor CROs, CPR has confidently risen to the challenge to exceed our sponsor expectations in all cases; often taking on projects rejected by our competitors as they are deemed too difficult to achieve.

With access to the Australian Regulatory Framework, our internationally renowned scientific team and our streamlined processes and practices, CPR has been able to assist sponsors to achieve their deadlines and minimise financial loss.  

CPR is the only bioanalytical facility in Australia to be successfully FDA inspected as a result of projects that required urgent assistance.

Join us on